These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6944181)

  • 21. Seric factors influence cell cycle modifications during commitment of murine erythroleukemia cells to differentiation.
    Mencherini F; Khochbin S; Chabanas A; Lawrence JJ
    Cytometry; 1992; 13(5):518-24. PubMed ID: 1633731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive and negative regulation of specific gene expression by the tumor promoter TPA in human erythroleukemic K562 cells.
    Siebert PD; Fukuda M
    Prog Clin Biol Res; 1985; 191():233-48. PubMed ID: 3863149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoids reversibly arrest rat hepatoma cell growth by inducing an early G1 block in cell cycle progression.
    Sánchez I; Goya L; Vallerga AK; Firestone GL
    Cell Growth Differ; 1993 Mar; 4(3):215-25. PubMed ID: 8466859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatty acid metabolism in phorbol ester-differentiating human leukemia cells.
    Cabot MC; Welsh CJ
    Cancer Res; 1981 Dec; 41(12 Pt 1):4910-5. PubMed ID: 7306991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early decrease of 2-deoxy glucose and alpha-amino isobutyric acid transport are among the first events in differentiating synchronized murine erythroleukemia cells.
    Gazitt Y
    J Cell Physiol; 1979 Jun; 99(3):407-16. PubMed ID: 287675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promoters.
    Laskin DL; Laskin JD; Kessler FK; Weinstein IB; Carchman RA
    Cancer Res; 1981 Nov; 41(11 Pt 1):4523-8. PubMed ID: 7306973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High resolution analysis of cell cycle-correlated vimentin expression in asynchronously grown, TPA-treated MPC-11 cells by the novel flow cytometric multiparameter BrdU-Hoechst/PI and immunolabeling technique.
    Giese G; Kubbies M; Traub P
    J Cell Physiol; 1994 Nov; 161(2):209-16. PubMed ID: 7525610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth arrest of AKR-2B cells maintained in the presence of epidermal growth factor or 12-O-tetradecanoylphorbol-13 acetate: evidence for two separate G1 arrest points.
    Moses HL; Proper JA; Volkenant ME; Swartzendruber DE
    J Cell Physiol; 1980 Mar; 102(3):367-78. PubMed ID: 6967071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Butyrate inhibits mouse fibroblasts at a control point in the G1 phase.
    Wintersberger E; Mudrak I; Wintersberger U
    J Cell Biochem; 1983; 21(3):239-47. PubMed ID: 6195168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of protein kinase C relays distinct signaling pathways in the same cell type: differentiation and caspase-mediated apoptosis.
    Meinhardt G; Roth J; Hass R
    Cell Death Differ; 2000 Sep; 7(9):795-803. PubMed ID: 11042674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor promoter-induced adhesion of the DS19 clone of murine erythroleukemia cells.
    Yamasaki H; Weinstein IB; Fibach E; Rifkind RA; Marks PA
    Cancer Res; 1979 Jun; 39(6 Pt 1):1989-94. PubMed ID: 286635
    [No Abstract]   [Full Text] [Related]  

  • 32. Enhanced transformation of mouse 10T1/2 cells by 12-O-tetradecanoylphorbol-13-acetate following exposure to X-rays or to fission-spectrum neutrons.
    Han A; Elkind MM
    Cancer Res; 1982 Feb; 42(2):477-83. PubMed ID: 7055800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initiator and promoter induced specific changes in epidermal function and biological potential.
    Yuspa SH; Hennings H; Lichti U
    J Supramol Struct Cell Biochem; 1981; 17(3):245-57. PubMed ID: 7328673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor promoter-induced inhibition of epidermal growth factor binding to cultured mouse primary epidermal cells.
    Lockyer JM; Bowden GT; Matrisian LM; Magun BE
    Cancer Res; 1981 Jun; 41(6):2308-14. PubMed ID: 6972249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell cycle progression and phenotypic modification of Ki67 antigen-negative G1- and G2-phase cells in phorbol ester-treated Molt-4 human leukemia cells.
    Tsurusawa M; Fujimoto T
    Cytometry; 1995 Jun; 20(2):146-53. PubMed ID: 7664625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics of appearance of differentiation-associated characteristics in ML-1, a line of human myeloblastic leukemia cells, after treatment with 12-O-tetradecanoylphorbol-13-acetate, dimethyl sulfoxide or 1-beta-D-arabinofuranosylcytosine.
    Takeda K; Minowada J; Bloch A
    Cancer Res; 1982 Dec; 42(12):5152-8. PubMed ID: 6958361
    [No Abstract]   [Full Text] [Related]  

  • 37. A phorbol ester tumor promoter induces changes in the expression of immunoglobulins and DR antigens in human lymphoblastoid cells.
    Roth P; Halper JP; Weinstein IB; Pernis B
    J Immunol; 1982 Aug; 129(2):539-44. PubMed ID: 6979576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of correlation between effects of tumor promoter TPA on plasminogen activator production, phosphatidyl choline synthesis, and hexose transport in mammalian cell culture systems.
    Plagemann PG; Estensen RD
    J Cell Physiol; 1980 Jul; 104(1):105-19. PubMed ID: 7192288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of 12-O-tetradecanoylphorbol-13-acetate on proliferation and maturation of human breast carcinoma cells (MCF-7): relationship to cell cycle events.
    Valette A; Gas N; Jozan S; Roubinet F; Dupont MA; Bayard F
    Cancer Res; 1987 Mar; 47(6):1615-20. PubMed ID: 3102047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Induction of baboon herpes virus antigens in producing lymphoblastoid cells].
    D'iachenko AG; Onishchuk FD
    Eksp Onkol; 1984; 6(5):46-9. PubMed ID: 6210192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.